Medication

FILE - In this Sept. 23, 2011 file photo, Rep. Thomas Marino, R-Pa., speaks during a news conference on Capitol Hill in Washington. Sen. Joe Manchin of West Virginia is demanding that the White House withdraw the nomination of Marino to be the nation's drug czar. Manchin says Marino played a key role in passing a bill weakening the Drug Enforcement Administration's authority to stop companies from distributing opioids. (AP Photo/Susan Walsh)
October 18, 2017 - 5:20 pm
WASHINGTON (AP) — President Donald Trump's former nominee to be the nation's drug czar is defending his role in writing a law that critics say weakened the government's authority to stop companies from distributing opioids. Rep. Tom Marino, R-Pa., said he's proud of his work on the 2016 law, which...
Read More
October 18, 2017 - 8:35 am
Anthem has found a new partner to help run prescription drug coverage after the Blue Cross-Blue Shield insurer's rocky relationship with Express Scripts ends. The nation's second-largest insurer says it will create a pharmacy benefits manager called IngenioRx starting in 2020 and will work with CVS...
Read More
FILE - In this July 16, 2012 file photo, Johnson & Johnson products are displayed in Orlando, Fla. Johnson & Johnson reports earnings, Tuesday, Oct. 17, 2017. (AP Photo/John Raoux, File)
October 17, 2017 - 8:39 am
Higher spending across the board drove Johnson & Johnson's third-quarter profit down 12 percent, despite a big sales jump fueled by recent acquisitions, hot new cancer drugs and strong sales of other key medicines. However, the health care giant easily topped Wall Street expectations. With...
Read More
October 09, 2017 - 6:46 am
BEIJING (AP) — China will allow use of some drugs and medical devices based on approval by foreign regulators, the government said Monday, in a move that could help to ease access to its health care market. The step was one of a series announced by Chinese drug regulators to improve access to...
Read More
FILE - In this Thursday, Sept. 28, 2017, file photo, patients lie in their beds at a hospital in Catano, Puerto Rico. The U.S. Food and Drug Administration says drug shortages are possible because of expected long-term power outages in Puerto Rico. FDA Commissioner Dr. Scott Gottlieb said in a statement Friday, Oct. 6, 2017, that the agency is working to prevent shortages of about 40 medicines. He didn't name the medicines involved. (AP Photo/Ramon Espinosa, File)
October 06, 2017 - 6:27 pm
The Food and Drug Administration on Friday warned that U.S. drug shortages are possible because power outages in Puerto Rico have stopped or limited production at many medicine factories there. Nearly 10 percent of the medicines used by Americans, plus numerous medical devices, are made in Puerto...
Read More
This April 26, 2017, photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. On Thursday, Sept. 28, 2017, the Food and Drug Administration approved Eli Lilly's Verzenio, a new medicine for treating adults with a common type of breast cancer that has spread. (AP Photo/Darron Cummings)
September 28, 2017 - 5:27 pm
U.S. regulators have approved a new medicine for treating a common type of breast cancer that has spread to other parts of the body. Eli Lilly's Verzenio (verr-ZEHN'ee-oh) was approved Thursday by the Food and Drug Administration for patients with what's called HR-positive, HER2-negative breast...
Read More
September 18, 2017 - 6:40 pm
TRENTON, N.J. (AP) — New Jersey Gov. Chris Christie said Monday that pharmaceutical companies agreed to work on nonaddictive pain medications and additional treatments to deal with opioid addiction. The Republican governor made the announcement in Trenton, shortly after he convened a meeting of the...
Read More
This photo provided by the Children’s Hospital of Philadelphia, taken in May 2017, shows Emily Whitehead five years after she became the first pediatric patient in the world to receive an experimental therapy at the hospital that has put her leukemia into long-term remission. Opening a new era in cancer care, the Food and Drug Administration (FDA) approved the first treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia. (Children’s Hospital of Philadelphia via AP)
August 30, 2017 - 12:44 pm
WASHINGTON (AP) — Opening a new era in cancer care, the Food and Drug Administration on Wednesday approved the first treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia. The CAR-T cell treatment developed by Novartis...
Read More
FILE - This Thursday, Dec.18, 2014, file photograph, shows the Merck logo on a stained glass panel at a Merck company building in Kenilworth, N.J. A new type of cholesterol drug meant to prevent heart attacks and other complications clearly did so, in an unusually large study whose results were announced Tuesday, Aug. 29, 2017, at a conference of heart specialists. But the daily pill only reduced those complications by 9 percent, leaving drugmaker Merck with a tough call on whether to seek regulatory approval after spending 13 years and likely hundreds of millions of dollars on testing. (AP Photo/Mel Evans, File)
August 29, 2017 - 2:35 am
TRENTON, N.J. (AP) — So-so results for a new type of cholesterol drug have left Merck in a quandary: Does the company try to bring it to market or scrap it? A large, long-term study of the drug showed that it prevents heart attacks and reduces the need for heart procedures, while three similar...
Read More
August 28, 2017 - 3:11 pm
PHILADELPHIA (AP) — A Pennsylvania man is suing health insurer Aetna, saying his sister learned he was taking HIV medication after the company mailed him an envelope with a large, clear window that showed information on where to purchase the drugs. The lawsuit filed Monday in U.S. District Court in...
Read More

Pages